Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
Clinical trial NCT00120796 · TERMINATED
Trial details
- NCT number
- NCT00120796
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2008-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.